Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.


TSXV:MPH - Post by User

Bullboard Posts
Comment by Sir_Holleron Apr 30, 2015 12:13pm
129 Views
Post# 23680879

RE:Extremely positive conference call

RE:Extremely positive conference call"CFO was very confident and talked about over 1 million cash on hand and going to increase every quarter. Aggrastat capturing market share from both competitors and also challenging Angiomax which has over 1 billion sales."

The confidence can be seen in the aggressiveness of the hiring. They have 1 salesperson for every two hospitals served. They are obviously very confident of orders to pay for the cost of the sales team as they ramp up geographical coverage. The number of hospitals served is going exponential on page nine of the presentation. The orders and re-orders are very smooth and predictable. Again, this predictability is supporting the aggressiveness of the hiring. Now in their second year of doubling sales this is becoming a pattern and given the market size the smart money should be here soon. That have also activated investment in their pipeline, includiing the transdermal version of their lead product.


https://www.medicure.com/upload/pdfs/investor_presentation.pdf
Bullboard Posts